These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30918324)

  • 1. Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus.
    Zhao J; Zhu M; Jiang H; Shen S; Su X; Shi Y
    Sci Rep; 2019 Mar; 9(1):5272. PubMed ID: 30918324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
    Naz F; Arish M
    Front Immunol; 2020; 11():1102. PubMed ID: 32670273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses.
    Jiang H; Shen SM; Yin J; Zhang PP; Shi Y
    PLoS One; 2017; 12(4):e0175188. PubMed ID: 28399143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
    Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
    Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.
    Oldstone MB; Teijaro JR; Walsh KB; Rosen H
    Virology; 2013 Jan; 435(1):92-101. PubMed ID: 23217619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).
    Shishkina LN; Skarnovich MO; Kabanov AS; Sergeev AA; Olkin SE; Tarasov SA; Belopolskaya MV; Sergeeva SA; Epstein OI; Malkova EM; Stavsky EA; Drozdov IG
    Bull Exp Biol Med; 2010 Oct; 149(5):612-4. PubMed ID: 21165400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.
    Liu B; Bao L; Wang L; Li F; Wen M; Li H; Deng W; Zhang X; Cao B
    J Microbiol Immunol Infect; 2021 Jun; 54(3):396-403. PubMed ID: 31780358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.
    Smee DF; Barnard DL; Jones SM
    Antiviral Res; 2016 Dec; 136():45-50. PubMed ID: 27771390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy.
    Matheu MP; Teijaro JR; Walsh KB; Greenberg ML; Marsolais D; Parker I; Rosen H; Oldstone MB; Cahalan MD
    PLoS One; 2013; 8(3):e58033. PubMed ID: 23533579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
    Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
    J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection.
    Geng ZK; Li YQ; Cui QH; DU RK; Tian JZ
    Chin J Nat Med; 2019 Sep; 17(9):650-662. PubMed ID: 31526500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
    Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
    Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
    Ye Y; Wang H; Liu J; Zhao F; Xu P
    Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
    Smee DF; Wong MH; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-viral activity of the complex glycyrrhizic acid-alpha-glutamyl-tryptophan against experimental lethal influenza infection in white mice caused by oseltamivir-resistant strain of the virus].
    Smirnov VS; Garshinina AV; Guseva VM; Kalinina NA; Shtro AA; Beliaevskaia SV; Anikin VB; Zarubaev VV
    Vopr Virusol; 2013; 58(5):19-26. PubMed ID: 24640167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy.
    Teijaro JR; Walsh KB; Long JP; Tordoff KP; Stark GV; Eisfeld AJ; Kawaoka Y; Rosen H; Oldstone MB
    Virology; 2014 Mar; 452-453():152-7. PubMed ID: 24606692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
    Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.